drugset / Trial / NCT01154621

Assessing the Safety and Tolerability of a Single IV Dose of AZD9742 in Healthy Elderly Male and Female Subjects

NCT01154621

Phase 1 Completed 12 enrolled AstraZeneca
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The aim of this study is to examine the safety and tolerability of a single dose of AZD9742 in elderly individuals.

Timeline

Start
2010-06
Primary completion
2010-07
Completion
2010-07

Drugs

EvaluationDrugModalityDoseRoute
Subject AZD9742 Unknown 750 mg Intravenous

Indications

No indication recorded.